Suppr超能文献

相似文献

2
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Mol Cancer Ther. 2007 Jul;6(7):1993-2002. doi: 10.1158/1535-7163.MCT-07-0118.
3
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.
Mol Cancer Ther. 2006 Feb;5(2):382-90. doi: 10.1158/1535-7163.MCT-05-0303.
9
Breaking the 'harmony' of TNF-α signaling for cancer treatment.
Oncogene. 2012 Sep 13;31(37):4117-27. doi: 10.1038/onc.2011.567. Epub 2011 Dec 12.

引用本文的文献

3
Advances in hydrogels for capturing and neutralizing inflammatory cytokines.
J Tissue Eng. 2025 Jun 25;16:20417314251342175. doi: 10.1177/20417314251342175. eCollection 2025 Jan-Dec.
6
Inflammation in cancer: therapeutic opportunities from new insights.
Mol Cancer. 2025 Feb 24;24(1):51. doi: 10.1186/s12943-025-02243-8.
7
Biomarkers of inflammation and colorectal cancer risk.
Front Oncol. 2025 Feb 6;15:1514009. doi: 10.3389/fonc.2025.1514009. eCollection 2025.
8
Cytokines in cancer.
Cancer Cell. 2025 Jan 13;43(1):15-35. doi: 10.1016/j.ccell.2024.11.011. Epub 2024 Dec 12.
9
Macrophage diversity in cancer dissemination and metastasis.
Cell Mol Immunol. 2024 Nov;21(11):1201-1214. doi: 10.1038/s41423-024-01216-z. Epub 2024 Oct 14.
10
Tumor necrosis factor superfamily signaling: life and death in cancer.
Cancer Metastasis Rev. 2024 Dec;43(4):1137-1163. doi: 10.1007/s10555-024-10206-6. Epub 2024 Oct 4.

本文引用的文献

2
The response of human epithelial cells to TNF involves an inducible autocrine cascade.
Cell. 2006 Mar 24;124(6):1225-39. doi: 10.1016/j.cell.2006.01.041.
3
Therapeutic potential of cytokine and chemokine antagonists in cancer therapy.
Eur J Cancer. 2006 Apr;42(6):793-802. doi: 10.1016/j.ejca.2006.01.013. Epub 2006 Mar 9.
4
Tumour necrosis factor-alpha as a tumour promoter.
Eur J Cancer. 2006 Apr;42(6):745-50. doi: 10.1016/j.ejca.2006.01.012. Epub 2006 Mar 6.
5
Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up.
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:183-9. doi: 10.1111/j.1525-1438.2006.00307.x.
6
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.
Mol Cancer Ther. 2006 Feb;5(2):382-90. doi: 10.1158/1535-7163.MCT-05-0303.
7
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.
Cell. 2006 Jan 27;124(2):263-6. doi: 10.1016/j.cell.2006.01.007.
8
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
Nature. 2005 Dec 8;438(7069):820-7. doi: 10.1038/nature04186.
10
Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
J Clin Oncol. 2005 Sep 1;23(25):5950-9. doi: 10.1200/JCO.2005.04.127.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验